phosphatidylcholines has been researched along with iloprost in 1 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (iloprost) | Trials (iloprost) | Recent Studies (post-2010) (iloprost) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 2,150 | 271 | 462 |
| Protein | Taxonomy | phosphatidylcholines (IC50) | iloprost (IC50) |
|---|---|---|---|
| Prostacyclin receptor | Homo sapiens (human) | 0.0112 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barre, DE | 1 |
1 other study(ies) available for phosphatidylcholines and iloprost
| Article | Year |
|---|---|
Human platelets have cholesteryl ester hydrolytic activity resulting in esterification of [1-14C]oleate to individual phospholipids of platelets.
Topics: Blood Platelets; Carbon Radioisotopes; Cholesterol Esters; Dideoxyadenosine; Esterification; Fatty Acids, Nonesterified; Humans; Hydrolysis; Iloprost; Isoquinolines; Kinetics; Oleic Acid; Oleic Acids; Phosphatidylcholines; Phosphatidylethanolamines; Phosphatidylinositols; Phosphatidylserines; Phospholipids; Phosphorylation; Protein Kinase Inhibitors; Sphingomyelins; Sulfonamides | 1995 |